Michigan Doubles Qualifying Conditions for Medical Cannabis to 22

LARA Director Approves Eleven New “Debilitating Medical Conditions” for Michigan Medical Marihuana Patients

July 9, 2018 – The Department of Licensing and Regulatory Affairs (LARA) Director Shelly Edgerton has approved adding eleven new medical conditions to the list of debilitating medical conditions set forth in the Michigan Medical Marihuana Act of 2008.

With the changes in state law to include marihuana-infused products, and the advancement of marihuana research, and upon the recommendation of the panel members, I’ve added these eleven conditions to the approved list. I’d like to thank the members of the review panel for their hard work in discussing these petitions and making their recommendations.

LARA Director Shelly Edgerton

The following conditions were approved by Edgerton after a majority of the Medical Marihuana Review Panel members recommended approval:

  • Arthritis
  • Autism
  • Chronic Pain
  • Colitis
  • Inflammatory Bowel Disease
  • Obsessive Compulsive Disorder
  • Parkinson’s
  • Rheumatoid Arthritis
  • Spinal Cord Injury
  • Tourette’s Syndrome
  • Ulcerative Colitis

The following conditions were denied by Edgerton after a majority of the Medical Marihuana Review Panel members recommended denial:

  • Anxiety
  • Asthma
  • Brain Injury
  • Depression
  • Diabetes
  • Gastric Ulcer
  • Non-Severe and Non-Chronic Pain
  • Organ Transplant
  • Panic Attacks
  • Schizophrenia
  • Social Anxiety Disorder

The Medical Marihuana Review Panel made their recommendations to Edgerton after receiving citizen comments in April and May related to the petitions to add these particular medical conditions to the list of debilitating medical conditions identified in the Michigan Medical Marihuana Act (MCL 333.26423). The approval or denial of the petitions by Edgerton are considered final department actions.

Effective immediately, these eleven conditions are now added to the following current list of debilitating medical conditions already approved for medical marihuana in the state of Michigan:

  • Post-Traumatic Stress Disorder
  • Cancer
  • Glaucoma
  • Positive status for Human Immunodeficiency Virus
  • Acquired Immune Deficiency Syndrome
  • Hepatitis C
  • Amyotrophic Lateral Sclerosis
  • Crohn’s Disease
  • Agitation of Alzheimer’s disease
  • Nail Patella, or the treatment of these conditions.
  • A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following:
    • Cachexia or Wasting Syndrome
    • Severe and chronic pain
    • Severe nausea
    • Seizures, including but not limited to those characteristic of epilepsy
    • Severe and persistent muscle spasms, including but not limited to those characteristic of multiple sclerosis

More information on the BMMR can be found at the bureau’s website

For more information about LARA, please visit www.michigan.gov/lara

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. For questions contact us.

Get Our Sunday Newsletter